In the latest classification by the World Health Organization (WHO) in 2022, ameloblastomas are categorized into various subtypes, including conventional (C‐ABL), unicystic (U‐ABL), extraosseous/peripheral, adenoid, and metastatic ameloblastoma (Soluk‐Tekkesin and Wright 2022). The gene discussed is ABL1; the disease is ameloblastoma.